RSLS Research and Charts

RSLS - Reshape Lifesciences Inc (Healthcare: Medical Devices)

Projected Earnings Date: 2024-08-16 (Delayed quote data 2025-08-14)

Last 3.92	Change ⇑ +0.72 (+22.50%)	Volume 13,741,358
	Open 3.02	High 4.65	Low 2.80

8EMA (Daily) 2.81	40EMA (Daily) 3.32	50EMA (Daily) 4.23	STO (Daily) 29.044	MACD Hist (Daily) 0.396
8EMA (Weekly) 3.286	40EMA (Weekly) 113.38	50EMA (Weekly) 343.01	STO (Weekly) 8.888	MACD Hist (Weekly) 26.201


Company Profile
Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.